The inhibition of cancer cell proliferation of ganoderic acid A is believed to be mediated via the downregulation of Cdk4 expression, while its antimetastatic effects appear to be mediated through the inhibition of AP-1/NF-κB-dependent secretion of urokinase plasminogen activator (uPA) [8]. The gene discussed is PLAU; the disease is cancer.